Single-Cell Research an Overview of Recent Single-Cell Research Publications Featuring Illumina® Technology
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
FINALIST DIRECTORY VIRTUAL REGENERON ISEF 2020 Animal Sciences
FINALIST DIRECTORY VIRTUAL REGENERON ISEF 2020 Animal Sciences ANIM001 Dispersal and Behavior Patterns between ANIM010 The Study of Anasa tristis Elimination Using Dispersing Wolves and Pack Wolves in Northern Household Products Minnesota Carter McGaha, 15, Freshman, Vici Public Schools, Marcy Ferriere, 18, Senior, Cloquet, Senior High Vici, OK School, Cloquet, MN ANIM011 The Ketogenic Diet Ameliorates the Effects of ANIM002 Antsel and Gretal Caffeine in Seizure Susceptible Drosophila Avneesh Saravanapavan, 14, Freshman, West Port melanogaster High School, Ocala, FL Katherine St George, 17, Senior, John F. Kennedy High School, Bellmore, NY ANIM003 Year Three: Evaluating the Effects of Bifidobacterium infantis Compared with ANIM012 Development and Application of Attractants and Fumagillin on the Honeybee Gut Parasite Controlled-release Microcapsules for the Nosema ceranae and Overall Gut Microbiota Control of an Important Economic Pest: Flower # Varun Madan, 15, Sophomore, Lake Highland Thrips, Frankliniella intonsa Preparatory School, Orlando, FL Chunyi Wei, 16, Sophomore, The Affiliated High School of Fujian Normal University, Fuzhou, ANIM004T Using Protease-activated Receptors (PARs) in Fujian, China Caenorhabditis elegans as a Potential Therapeutic Agent for Inflammatory Diseases ANIM013 The Impacts of Brandt's Voles (Lasiopodomys Swetha Velayutham, 15, Sophomore, brandtii) on the Growth of Plantations Vyshnavi Poruri, 15, Sophomore, Surrounding their Patched Burrow Units Plano East, Senior High School, Plano, TX Meiqi Sun, 18, Senior, -
Single-Cell Transcriptome Analysis As a Promising Tool to Study Pluripotent Stem Cell Reprogramming
International Journal of Molecular Sciences Review Single-Cell Transcriptome Analysis as a Promising Tool to Study Pluripotent Stem Cell Reprogramming Hyun Kyu Kim †, Tae Won Ha † and Man Ryul Lee * Soonchunhyang Institute of Medi-Bio Science (SIMS), Soon Chun Hyang University, Cheonan 31151, Korea; [email protected] (H.K.K.); [email protected] (T.W.H.) * Correspondence: [email protected]; Tel.: +81-41-413-5013 † These authors equally contributed to this work. Abstract: Cells are the basic units of all organisms and are involved in all vital activities, such as proliferation, differentiation, senescence, and apoptosis. A human body consists of more than 30 trillion cells generated through repeated division and differentiation from a single-cell fertilized egg in a highly organized programmatic fashion. Since the recent formation of the Human Cell Atlas consortium, establishing the Human Cell Atlas at the single-cell level has been an ongoing activity with the goal of understanding the mechanisms underlying diseases and vital cellular activities at the level of the single cell. In particular, transcriptome analysis of embryonic stem cells at the single-cell level is of great importance, as these cells are responsible for determining cell fate. Here, we review single-cell analysis techniques that have been actively used in recent years, introduce the single-cell analysis studies currently in progress in pluripotent stem cells and reprogramming, and forecast future studies. Keywords: single-cell mRNA sequencing; pluripotent stem cell; somatic cell reprogramming; in- duced pluripotent stem cell; heterogeneity Citation: Kim, H.K.; Ha, T.W.; Lee, M.R. Single-Cell Transcriptome Analysis as a Promising Tool to Study Pluripotent Stem Cell Reprogramming. -
PBMC Fixation and Processing for Chromium Single-Cell RNA Sequencing
bioRxiv preprint doi: https://doi.org/10.1101/315267; this version posted May 5, 2018. The copyright holder has placed this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, reuse, remix, or adapt this material for any purpose without crediting the original authors. PBMC Fixation and Processing for Chromium Single-Cell RNA Sequencing Jinguo Chen1, Foo Cheung1, Rongye Shi1,2, Huizhi Zhou1,2, Wenrui Lu1,3, CHI Consortium1 1Center for Human Immunology, Autoimmunity and Inflammation (CHI), National Institutes of Health 2Department of Transfusion Medicine, Clinical Center, National Institutes of Health 3Fujian Provincial Hospital, Fuzhou, China CHI Consortium (Julián Candia1, Yuri Kotliarov1, Katie R. Stagliano1 and John S. Tsang1,2) 1 CHI 2 Systems Genomics and Bioinformatics Unit, NIAID Abstract Background: Interest in single-cell transcriptomic analysis is growing rapidly, especially for profiling rare or heterogeneous populations of cells. In almost all reported works, investigators have used live cells which introduces cell stress during preparation and hinders complex study designs. Recent studies have indicated that cells fixed by denaturing fixative can be used in single-cell sequencing. But they did not work with most primary cells including immune cells. Methods: The methanol-fixation and new processing method was introduced to preserve PBMCs for single-cell RNA sequencing (scRNA-Seq) analysis on 10X Chromium platform. Results: When methanol fixation protocol was broken up into three steps: fixation, storage and rehydration, we found that PBMC RNA was degraded during rehydration with PBS, not at cell fixation and up to three-month storage steps. -
The Economic Impact and Functional Applications of Human Genetics and Genomics
The Economic Impact and Functional Applications of Human Genetics and Genomics Commissioned by the American Society of Human Genetics Produced by TEConomy Partners, LLC. Report Authors: Simon Tripp and Martin Grueber May 2021 TEConomy Partners, LLC (TEConomy) endeavors at all times to produce work of the highest quality, consistent with our contract commitments. However, because of the research and/or experimental nature of this work, the client undertakes the sole responsibility for the consequence of any use or misuse of, or inability to use, any information or result obtained from TEConomy, and TEConomy, its partners, or employees have no legal liability for the accuracy, adequacy, or efficacy thereof. Acknowledgements ASHG and the project authors wish to thank the following organizations for their generous support of this study. Invitae Corporation, San Francisco, CA Regeneron Pharmaceuticals, Inc., Tarrytown, NY The project authors express their sincere appreciation to the following indi- viduals who provided their advice and input to this project. ASHG Government and Public Advocacy Committee Lynn B. Jorde, PhD ASHG Government and Public Advocacy Committee (GPAC) Chair, President (2011) Professor and Chair of Human Genetics George and Dolores Eccles Institute of Human Genetics University of Utah School of Medicine Katrina Goddard, PhD ASHG GPAC Incoming Chair, Board of Directors (2018-2020) Distinguished Investigator, Associate Director, Science Programs Kaiser Permanente Northwest Melinda Aldrich, PhD, MPH Associate Professor, Department of Medicine, Division of Genetic Medicine Vanderbilt University Medical Center Wendy Chung, MD, PhD Professor of Pediatrics in Medicine and Director, Clinical Cancer Genetics Columbia University Mira Irons, MD Chief Health and Science Officer American Medical Association Peng Jin, PhD Professor and Chair, Department of Human Genetics Emory University Allison McCague, PhD Science Policy Analyst, Policy and Program Analysis Branch National Human Genome Research Institute Rebecca Meyer-Schuman, MS Human Genetics Ph.D. -
Shapes TCR Usage in Celiac Disease Posttranslational Modification of Gluten
Posttranslational Modification of Gluten Shapes TCR Usage in Celiac Disease Shuo-Wang Qiao, Melinda Ráki, Kristin S. Gunnarsen, Geir-Åge Løset, Knut E. A. Lundin, Inger Sandlie and This information is current as Ludvig M. Sollid of September 29, 2021. J Immunol 2011; 187:3064-3071; Prepublished online 17 August 2011; doi: 10.4049/jimmunol.1101526 http://www.jimmunol.org/content/187/6/3064 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2011/08/18/jimmunol.110152 Material 6.DC1 http://www.jimmunol.org/ References This article cites 31 articles, 12 of which you can access for free at: http://www.jimmunol.org/content/187/6/3064.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 29, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Posttranslational Modification of Gluten Shapes TCR Usage in Celiac Disease Shuo-Wang Qiao,* Melinda Ra´ki,†,1 Kristin S. -
Verification Activities: Sonia Salas
Verification Activities: New and Emerging Technologies Sonia Salas Verification Activities: New and Emerging Technologies • Verification: Methods, procedures, tests and other evaluations, in addition to monitoring, to determine whether a control measure or combination of control measures is or has been operating as intended and to establish the validity of the food safety plan (Source: FDA Industry Guidance: Control of Listeria monocytogenes in RTE Foods) • Verification activities include: validation, verification that monitoring is being conducted as required, verification of implementation and effectiveness, verification that appropriate decisions about corrective actions are being made and reanalysis (Source: PC Rule §117.155) Verification Activities: New and Emerging Technologies What new and emerging technologies can assist the produce sector in determining whether Listeria preventive controls are or have been operating as intended in a food safety plan? Verification Activities: New and Emerging Technologies Listeria controls (Source: FDA Industry Guidance: Control of Listeria monocytogenes in RTE Foods) • Controls on personnel • Design, construction and operation of a plant • Design, construction and maintenance of equipment • Sanitation • Storage practices and time/temperature controls • Transportation • Training • Controls on raw materials and ingredients • Process control based on formulating a RTE food • Listericial process control Verification Activities: New and Emerging Technologies – Whole Genome Sequencing (WGS) – Nanotechnology -
Clinical Whole Genome Sequencing
PRODUCT DATASHEET CLIA Certified and College of American Clinical Whole Pathologists (CAP) accredited Genome Built around our tried and tested PCR-Free Sequencing whole genome sequencing process OVERVIEW WHAT’S INCLUDED Clinical Human Whole Genome Sequencing provides validated, high quality sequence data generated through the same pro- • Sample receipt and nucleic acid extraction from blood cesses that have produced >100,000 research genomes - in- • QC & plating, sample preparation cluding genomes that have been included in large resource • Sample fidelity QC (96 SNP fingerprinting) datasets such as TOPMed and GnoMAD. Our in-house devel- oped, PCR-Free library construction process produces ex- • 2x150bp paired sequencing reads tremely even coverage of the entire genome, including exonic, • Coverage of ≥95% of bases ≥20x intronic, GC-rich, and regulatory regions. • Data delivery through a secure online portal Whole genome sequencing offers several advantages over tra- • Turnaround time ≤28 days from sample receipt ditional approaches of genomic characterization. Targeted pan- el and exome approaches require amplification of genomic DNA PERFORMANCE METRICS which induces sequence-context specific bias. Analyses of panels and exomes is limited to targeted regions and content % Bases at 20X Target: ≥95% must be updated if new regions are identified for study. Sever- Mean Coverage Target for Genome: ≥30X WGS Coverage al classes of human variation including copy number profiling and structural variation calling are more easily and accurately % Contamination: ≤2.5% (typically less than 0.2%) determined from whole genome sequencing. PF HQ Aligned Bases: ≥8x1010 bases Technical performance specifications for our clinical whole genome were determined through pre-validation analysis of Estimated Library Size: ≥7x109 molecules >20,000 research genomes as well as through input received SNV Sensitivity: 98.8% from our medical and population genetics community. -
Exome Sequencing in Gastrointestinal Food Allergies Induced by Multiple Food Proteins
Exome Sequencing in Gastrointestinal Food Allergies Induced by Multiple Food Proteins Alba Sanchis Juan Department of Biotechnology Universitat Politècnica de València Supervisors: Dr. Javier Chaves Martínez Dr. Ana Bárbara García García Dr. Pablo Marín García This dissertation is submitted for the degree of Doctor of Philosophy September 2019 If you know you are on the right track, if you have this inner knowledge, then nobody can turn you off... no matter what they say. Barbara McClintock Declaration FELIPE JAVIER CHAVES MARTÍNEZ, PhD in Biological Sciences, ANA BÁRBARA GARCÍA GARCÍA, PhD in Pharmacy, and PABLO MARÍN GARCÍA, PhD in Biological Sciences, CERTIFY: That the work “Exome Sequencing in Gastrointestinal Food Allergies Induced by Multiple Food Proteins” has been developed by Alba Sanchis Juan under their supervision in the INCLIVA Biomedical Research Institute, as a Thesis Project in order to obtain the degree of PhD in Biotechnology at the Universitat Politècnica de València. Dr. F. Javier Chaves Martínez Dr. Ana Bárbara García García Dr. Pablo Marín García Acknowledgements Reaching the end of this journey, after so many ups and downs, I cannot but express my gratitude to all those who supported me and helped me through this challenging but rewarding experience. First and foremost, I would like to thank my supervisors, Dr. Javier Chaves Martinez, Dr. Ana Barbara García García and Dr. Pablo Marín García. They gave me the opportunity to work with them when I was still an undergraduate student, and provided me the opportunity to contribute to several exciting projects since then. They also encouraged me into the clinical genomics field and provided me guidance and advice throughout the last four years. -
Single-Cell Sequencing for Precise Cancer Research: Progress and Prospects Xiaoyan Zhang1, Sadie L
Published OnlineFirst March 3, 2016; DOI: 10.1158/0008-5472.CAN-15-1907 Cancer Review Research Single-Cell Sequencing for Precise Cancer Research: Progress and Prospects Xiaoyan Zhang1, Sadie L. Marjani2, Zhaoyang Hu1, Sherman M. Weissman3, Xinghua Pan1,3,4, and Shixiu Wu1 Abstract Advances in genomic technology have enabled the faithful could potentially improve the early detection and monitoring detection and measurement of mutations and the gene expres- of rare cancer cells, such as circulating tumor cells and dissem- sion profile of cancer cells at the single-cell level. Recently, inated tumor cells, and promote the development of person- several single-cell sequencing methods have been developed alized and highly precise cancer therapy. Here, we discuss that permit the comprehensive and precise analysis of the the current methods for single cancer-cell sequencing, with a cancer-cell genome, transcriptome, and epigenome. The use of strong focus on those practically used or potentially valuable these methods to analyze cancer cells has led to a series of in cancer research, including single-cell isolation, whole unanticipated discoveries, such as the high heterogeneity and genome and transcriptome amplification, epigenome profiling, stochastic changes in cancer-cell populations, the new driver multi-dimensional sequencing, and next-generation sequenc- mutations and the complicated clonal evolution mechanisms, ing and analysis. We also examine the current applications, and the novel identification of biomarkers of variant tumors. challenges, and prospects of single cancer-cell sequencing. These methods and the knowledge gained from their utilization Cancer Res; 76(6); 1–8. Ó2016 AACR. Introduction disease progression (4). However, the molecular profiling data, especially heterogeneity analysis, of these important cancer-cell Cancer is a significant cause of mortality worldwide. -
The Revolutionizing Prospects of Next Generation DNA Sequencing Of
Schlundt J and Tay MYF, J Food Sci Nutr 2020, 6: 072 DOI: 10.24966/FSN-1076/100072 HSOA Journal of Food Science and Nutrition Review Article this has been a major problem in the past, novel DNA sequenc- The Revolutionizing Prospects ing methodologies are now providing promising new potential. The case is made for the potential to develop a global, equitable sys- of Next Generation DNA tem of whole microbial genome databases to aggregate, share, mine and use microbiological genomic data, to address global food Sequencing of Microorganisms safety and public health challenges and most importantly to reduce for Microbiological and foodborne and infectious disease burden. Keywords: Antimicrobial resistance; Food safety; Genomic data AMR Identification and sharing; Global microbial identifier; Microbiology; Next generation Characterization-the GMI sequencing; One health; Surveillance; Zoonotic diseases Singapore Sequencing Statement Abbreviations AGP: Antimicrobial Growth Promoters; Joergen Schlundt1,2* and Moon Yue Feng Tay1,2 AMR: Antimicrobial Resistance; 1School of Chemical and Biomedical Engineering, Nanyang Technological BSE: Bovine Spongiform Encephalopathy; University (NTU), 62 Nanyang Drive, Singapore EHEC: Enterohaemorrhagic Escherichia Coli; EFSA: European Food Safety Authority; 2Nanyang Technological University Food Technology Centre (NAFTEC), Nanyang Technological University (NTU), Singapore FAO: Food and Agriculture Organization of the United Nations; GFN: Global Foodborne Infections Network; GMI: Global Microbial Identifier; INFOSAN: International Food Safety Authorities Network; Abstract MERS: Middle East Respiratory Syndrome; A cascade of technological DNA sequencing advancements has MDR: Multidrug Resistant; decreased the cost of Whole Genome Sequencing (WGS) very fast. NGS: Next Generation Sequencing; At the same time, the enormous potential of WGS in the surveil- SARS: Severe Acute Respiratory Syndrome; lance of microorganisms and Antimicrobial Resistance (AMR) is in- WGS: Whole Genome Sequencing; creasingly realized. -
Overview of Whole Genome Sequencing
Whole genome sequencing The impact of new DNA sequencing technologies for health In the light of rapid developments in DNA sequencing technologies, we find ourselves on the brink of a new era of genomic medicine in which whole genome sequencing (WGS) becomes an affordable clinical reality. There is no longer any question that within the next few years it will be possible to sequence a full human genome at a speed and cost that will open up unprecedented new opportunities for health care. Pressure is now mounting to ensure that this potential is promptly, effectively and responsibly harnessed for a real impact on health. To meet this challenge, important questions must be considered: • What is the role of WGS technologies in medicine and public health? • How will they affect routine clinical practice and the wider public, and what ethical and legal issues do they raise? • What operational barriers exist to adoption within health services, and how should they be tackled? The PHG Foundation has launched a major new programme to evaluate and address the implications of WGS for health and society. As an independent genetics think-tank and acknowledged founder of the field of public health genomics, we have been at the forefront of efforts to catalyse the timely and responsible application of useful biomedical innovation into health practice for over a decade. Our aim is to identify the best health applications of WGS technologies and recommend strategies that will be pivotal in directing their adoption into health services to improve patient care. We believe that the best approach is to work together with forward-thinking sector leaders to make this happen, and are seeking partners and supporters for this programme. -
Polish Roadmap for Research Infrastructures Polish Roadmap for Research Infrastructures
Polish Roadmap for Research Infrastructures Polish Roadmap for Research Infrastructures Preface Research plays a key role in the development of soci- ety and civilization. Through research we are able to ef- fectively address new challenges such as quality of life, civilization diseases, demographic changes, sustainable development and environmental protection, as well as energy security. Without top-level research it is impos- sible not only to successfully face the above mentioned and other challenges but also to understand the dy- Wojciech Murdzek namically changing world. Minister of Science and Higher Education There are two elements of vital importance for research excellence – human capital and state-of-the-art re- search infrastructures. The latter is doubly important owing to its essential role in training future scientific and technical staff. Major strategic research infrastruc- tures attract world-class scientists and innovative com- panies which enables economic growth as well as en- hance social capital. Excellent laboratories applying the highest standards of research and education are there- fore necessary for each country to develop. The Polish Roadmap for Research Infrastructures is a tool created to facilitate the development of these laboratories. It comprises seventy of the most ambitious research infrastructure projects of great socio-econom- ic significance, chosen through a transparent process carried out in accordance with international standards. The Roadmap is to become the basis for the investment policy of the Ministry of Science and Higher Education in the coming years, however it is worth underlining that placing a research infrastructure project on the Roadmap does not automatically imply the financial commitment of the Ministry.